Coherus Biosciences Inc (NASDAQ: CHRS) is -42.03% lower on its value in year-to-date trading and has touched a low of $0.66 and a high of $2.43 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CHRS stock was last observed hovering at around $0.76 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $0.80, the stock is -16.97% and -14.27% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.81 million and changing 5.12% at the moment leaves the stock -29.19% off its SMA200. CHRS registered -63.30% loss for a year compared to 6-month gain of 2.74%.
The stock witnessed a -28.57% loss in the last 1 month and extending the period to 3 months gives it a -28.57%, and is -21.57% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.48% over the week and 8.87% over the month.
Coherus Biosciences Inc (CHRS) has around 228 employees, a market worth around $92.75M and $197.50M in sales. Profit margin for the company is -66.30%. Distance from 52-week low is 21.16% and -67.08% from its 52-week high. The company has generated returns on investments over the last 12 months (-114.62%).
The EPS is expected to shrink by -611.36% this year.
Coherus Biosciences Inc (CHRS) Top Institutional Holders
The shares outstanding are 115.91M, and float is at 111.33M with Short Float at 29.25%.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.75 million shares valued at $20.33 million. The investor’s holdings represent 10.2356% of the CHRS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.6 million shares valued at $18.34 million to account for 9.2339 of the shares outstanding. The other top investors are RUBRIC CAPITAL MANAGEMENT LP which holds 10.4 million shares representing 9.0577% and valued at over $17.99 million, while TEMASEK HOLDINGS (PRIVATE) LTD holds 5.0678 of the shares totaling 5.82 million with a market value of $10.07 million.
Coherus Biosciences Inc (CHRS) Insider Activity
#####